Author Archive

Hear from our authors: Eva Kudová, Stanislav Chvíla and František Štěpánek

RSC Pharmaceutics recently published its first articles, which can be read for free here. To celebrate publishing our first articles, we asked some of our authors to discuss their work in more detail.

In this post, we hear about the research from Chvíla et al. in their article titled “A zuranolone nanocrystal formulation enables solubility-independent in vivo study of pentylenetetrazol-induced seizures in a rat model”. Watch three of the authors, Eva Kudová, Stanislav Chvíla and František Štěpánek, talk about their work below or here!

A zuranolone nanocrystal formulation enables solubility-independent in vivo study of pentylenetetrazol-induced seizures in a rat model

Stanislav Chvíla, Hana Kubová, Pavel Mareš, Eva Kudová and František Štěpánek

RSC Pharm., 2024, Advance Article.

DOI: 10.1039/D3PM00043E

RSC Pharmaceutics provides researchers with a platform to publish research in pharmaceutics and advance this field. We are interested in any submission that shares new scientific findings across chemistry, materials science, biomedical sciences, pharmaceutics and drug delivery.

Sign up for email alerts and submit your manuscript.

 

RSC Pharmaceutics – first articles now online

Explore the first articles from RSC Pharmaceutics

We are delighted to share the first articles from RSC Pharmaceutics. Our new journal publishes crucial research on pharmaceutics, which has the potential to drive real change in worldwide health. Every article is gold open access, so you can read and be inspired for free.

Dextrin conjugation to colistin inhibits its toxicity, cellular uptake and acute kidney injury in vivo

Mathieu Varache, Siân Rizzo, Edward J. Sayers, Lucy Newbury, Anna Mason, Chia-Te Liao, Emilie Chiron, Nathan Bourdiec, Adam Jones, Donald J. Fraser, Philip R. Taylor, Arwyn T. Jones, David W. Thomas and Elaine L. Ferguson

RSC Pharm., 2024, Advance Article,
DOI: 10.1039/D3PM00014A

Indocyanine green within glycosylated polymeric micelles as potential image agents to map sentinel lymph nodes and breast cancer

Nicole Lecot, Marcelo Fernández-Lomónaco, Hugo Cerecetto, Juan Pablo Gambini, Pablo Cabral and Romina Glisoni

RSC Pharm., 2024, Advance Article,
DOI: 10.1039/D3PM00053B

A zuranolone nanocrystal formulation enables solubility-independent in vivo study of pentylenetetrazol-induced seizures in a rat model

Stanislav Chvíla, Hana Kubová, Pavel Mareš, Eva Kudová and František Štěpánek

RSC Pharm., 2024, Advance Article,
DOI: 10.1039/D3PM00043E

These articles and our future publications are free to access by anyone.

Start reading now

RSC Pharmaceutics provides researchers with a platform to publish research in pharmaceutics and advance this field. We are interested in any submission that shares new scientific findings across chemistry, materials science, biomedical sciences, pharmaceutics and drug delivery.

Sign up for email alerts and submit your manuscript.

Meet our Associate Editor, Heidi Mansour

We are delighted to introduce you to our new RSC Pharmaceutics Associate Editor, Heidi Mansour.

Dr. Mansour is currently a Professor and Program Leader of Drug Discovery and Delivery at the Florida International University (FIU) Center for Translational Science located in Port Saint Lucie, Florida, on the beautiful Treasure Coast.

Read more about Professor Mansour here.

Read some of Professor Mansour’s research here:

Glycosylated Ang-(1-7) MasR Agonist Peptide Poly Lactic-co-Glycolic Acid (PLGA) Nanoparticles and Microparticles in Cognitive Impairment: Design, Particle Preparation, Physicochemical Characterization, and In Vitro Release
David Encinas-Basurto, John P. Konhilas, Robin Polt, Meredith Hay and Heidi M. Mansour
Pharmaceutics, 2022, 14, 587.

Advanced design and development of nanoparticle/microparticle dual-drug combination lactose carrier-free dry powder inhalation aerosols
Priya Muralidharan, Evan K. Mallory, Monica Malapit, Hanna Phan, Julie G. Ledford, Don Hayes, Jr and Heidi M. Mansour
RSC Adv., 2020, 10, 41846-41856.

Microparticulate/nanoparticulate powders of a novel Nrf2 activator and an aerosol performance enhancer for pulmonary delivery targeting the lung Nrf2/Keap-1 pathway
Priya Muralidharan, Don Hayes, Jr., Stephen M. Black and Heidi M. Mansour
Mol. Syst. Des. Eng., 2016, 1, 48-65.

RSC Pharmaceutics is a new gold open access journal from the Royal Society of Chemistry and publishes research focused on formulating a drug into a medicine, with the intention of achieving controllable drug delivery with high efficacy. This journal is now open for submissions.

 

Meet our Associate Editor, Assaf Zinger

We are delighted to introduce you to our new RSC Pharmaceutics Associate Editor Assaf Zinger.

Dr. Assaf Zinger is a leading researcher and educator specializing in nanomedicine and engineering. He is currently an Assistant Professor at the Technion-Israel Institute of Technology and an Adjunct Assistant Professor at the Houston Methodist Academic Institute in Texas, USA. Dr. Zinger’s research focuses on biomimetic nanoparticles, covering various fields from biochemical engineering, where he designs and tests these nanoparticles, to biomedical engineering, where he assesses their effectiveness against conditions like neurodegenerative diseases, brain injuries, and cancers. Read more about Dr. Zinger here.

 

Read some of Dr Zinger’s research here:

Unleashing the potential of cell biomimetic nanoparticles: Strategies and challenges in their design and fabrication for therapeutic applications

Assaf Zinger

J. Controlled Release, 2023, 358, 591-600.

 

Enhancing Inflammation Targeting Using Tunable Leukocyte-Based Biomimetic Nanoparticles

Assaf Zinger, Manuela Sushnitha, Tomoyuki Naoi, Gherardo Baudo, Enrica De Rosa, Jenny Chang, Ennio Tasciotti and Francesca Taraballi

ACS Nano, 2021, 15, 6326-6339.

 

RSC Pharmaceutics is a new gold open access journal from the Royal Society of Chemistry and publishes research focused on formulating a drug into a medicine, with the intention of achieving controllable drug delivery with high efficacy. This journal is now open for submissions.

 

 

Meet our Associate Editor, Xiaoxuan Liu

 

We are delighted to introduce you to our new RSC Pharmaceutics Associate Editor, Xiaoxuan Liu.

Xiaoxuan Liu is a Professor at the Center of Advanced Pharmaceuticals and Biomaterials in China Pharmaceutical University. Her research interest focuses on the development of novel dendrimer based nanosystems via modular self-assembling process for on-demand delivery of drugs and nucleic acid therapeutics in precision medicine.

Read more about Professor Liu here.

 

Read some of Professor Liu’s research here:

Cargo-selective and adaptive delivery of nucleic acid therapeutics by bola-amphiphilic dendrimers

Jiaxuan Chen, Dandan Zhu, Baoping Lian, Kangjie Shi, Peng Chen, Ying Li, Wenyi Lin, Ling Ding, Qiulin Long, Yang Wang, Erik Laurini, Wenjun Lan, Yun Li, Aura Tintaru, Caoyun Ju, Can Zhang, Sabrina Pricl, Juan Iovanna, Xiaoxuan Liu and Ling Peng

Proc. Natl. Acad. Sci. U.S.A., 2023, 120, e2220787120.

 

A biodegradable amphiphilic poly(aminoester) dendrimer for safe and effective siRNA delivery

Chi Ma, Dandan Zhu, Wenyi Lin, Ying Li, Yuanzheng Huang, Huiling Zhu, Mengyun Ye, Yang Wang, Ling Peng and Xiaoxuan Liu

Chem. Commun., 2022, 58, 4168-4171.

 

An amphiphilic dendrimer as a light-activable immunological adjuvant for in situ cancer vaccination

Yongchao Wang, Ningqiang Gong, Chi Ma, Yuxuan Zhang, Hong Tan, Guangchao Qing, Jimei Zhang, Yufei Wang, Jinjin Wang, Shizhu Chen, Xianlei Li, Qiankun Ni, Yuan Yuan, Yaling Gan, Junge Chen, Fangzhou Li, Jinchao Zhang, Caiwen Ou, Yongxiang Zhao, Xiaoxuan Liu and Xing-Jie Liang

Nat. Commun., 2021, 12, 4964.

 

RSC Pharmaceutics is a new gold open access journal from the Royal Society of Chemistry and publishes research focused on formulating a drug into a medicine, with the intention of achieving controllable drug delivery with high efficacy. This journal is now open for submissions.

 

Meet our Associate Editor, Clare Hoskins

We are delighted to introduce you to our RSC Pharmaceutics Associate Editor, Clare Hoskins.

Clare Hoskins is a Professor of Nanomedicine within the Department of Pure and Applied Chemistry, University of Strathclyde. Her research focusses on the development of various nanotechnology platforms for drug delivery and theranostics, with a special focus on cancer nanomedicine.

You can find out more about Professor Hoskins here.

RSC Pharmaceutics is a new gold open access journal leading the way in the field of Pharmaceutics. This journal publishes research focused on formulating a drug into a medicine, with the intention of achieving controllable drug delivery with high efficacy. Read our full scope statement and submit your manuscript on our webpage.

Introducing our RSC Pharmaceutics Editor-in-Chief

 

We are delighted to introduce you to Professor Yvonne Perrie, Editor-in-Chief of the new Royal Society of Chemistry journal RSC Pharmaceutics.

Yvonne Perrie is a Professor in Drug Delivery within the Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Scotland. Professor Perrie’s research is multi-disciplinary and focuses on developing drug delivery systems to facilitate the delivery of drugs and vaccines, thus providing practical solutions for current healthcare problems. Read more on our webpage.

 

 

Read some of her research here:

The role of nanoparticle format and route of administration on self-amplifying mRNA vaccine potency

Giulia Anderluzzi, Gustavo Lou, Stuart Woods, Signe Tandrup Schmidt, Simona Gallorini, Michela Brazzoli, Russell Johnson, Craig W. Roberts, Derek T. O’Hagan, Barbara C. Baudner and Yvonne Perrie

J. Control. Release, 2022, 342, 388-399.

 

Mixing and flow-induced nanoprecipitation for morphology control of silk fibroin self-assembly

Saphia A. L. Matthew, Refaya Rezwan, Jirada Kaewchuchuen, Yvonne Perrie and F. Philipp Seib

RSC Adv., 2022, 12, 7357-7373.

 

RSC Pharmaceutics is a new gold open access journal leading the way in the field of Pharmaceutics. This journal publishes research focused on formulating a drug into a medicine, with the intention of achieving controllable drug delivery with high efficacy. Read our full scope statement on our webpage.

RSC Pharmaceutics opens for submissions later this year, sign up for e-alerts to be the first to find out news about the journal.

 

Introducing RSC Pharmaceutics

Placing pharmaceutics at the forefront of health solutions

RSC Pharmaceutics will be a place for you to explore and publish crucial research in pharmaceutics. This journal will harness the power of chemistry and related disciplines to build a healthier world for all.

You can expect compelling publications that cover emerging technologies and techniques in pharmaceutics, including drug delivery, precision medicine and enhanced drug targeting.

Find out more on our webpage.

 

Introducing our editor-in-chief

 

 

There are many exciting updates to come, including details on our editorial board and scope. Sign up for alerts to hear more.